Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatmentTomohiro Yabushita, Susumu Goyama, Keiko Kato et al.|Cell Reports|2023Cited by 28
The molecular basis of myeloid malignanciesToshio Kitamura, Jiro Kitaura, Daichi Inoue et al.|Proceedings of the Japan Academy Series B|2014Cited by 23
HHEX promotes myeloid transformation in cooperation with mutant ASXL1Reina Takeda, Toshio Kitamura, Shuhei Asada et al.|Blood|2020Cited by 18
Phenylalanine hydroxylase activity in isolated, perfused liver of rats bearing rhodamine sarcoma, hepatoma, and nodular hyperplasia.Ayako Terawaki, Nobuyasu Ito, M. Sato et al.|PubMed|1967Cited by 1
The molecular basis of myeloid malignanciesToshio Kitamura, Jiro Kitaura, Daichi Inoue et al.|Proceedings of the Japan Academy|2014Cited by 0